Back
Sinopharm Group 10K Form
Buy
51
SHTDY
Sinopharm Group
Last Price:
14.03
Seasonality Move:
4.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SHTDY News And Ratings
See the #1 stock for the next 7 days that we like better than SHTDY
SHTDY Financial Statistics
Sales & Book Value
| Annual Sales: | $84.34B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $16.65 |
| Price / Book: | 0.83 |
Profitability
| EPS (TTM): | 1.92480 |
|---|---|
| Net Income (TTM): | $1.2B |
| Gross Margin: | $6.86B |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Sinopharm Group Earnings Forecast
Key Sinopharm Group Financial Ratios
- The Gross Profit Margin over the past 18 years for SHTDY is 8.13%.
- The Selling, General & Administrative Expenses for SHTDY have been equal to 4.38% of Gross Profit Margin.
- The Interest Expense is 32.66% of Operating Income.
- The Net Earning history of SHTDY is 1.52% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 16 years.
Sinopharm Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | SHTDY |
| Website: | sinopharmgroup.com.cn |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 6.71 |
|---|---|
| Forward P/E Ratio: | 0 |
SHTDY Technical Analysis vs Fundamental Analysis
Buy
51
Sinopharm Group (SHTDY)
is a Buy
Is Sinopharm Group a Buy or a Sell?
-
Sinopharm Group stock is rated a Buy
The current Sinopharm Group [SHTDY] share price is $14.03. The Score for SHTDY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.